Phil Tibbo
Professor
Email: Phil.Tibbo@nshealth.ca
Phone: 902-473-1678
Mailing Address:
Nova Scotia Early Psychosis Program
Room 3030, 3rd Floor, AJLB
5909 Veterans Memorial Lane
Halifax, NS B3H 2E2
Research Topics:Room 3030, 3rd Floor, AJLB
5909 Veterans Memorial Lane
Halifax, NS B3H 2E2
- Early phase psychosis and schizophrenia
- Early intervention services
- Neuroimaging (MRS/DTI)
- Comorbid substance use (Cannabis)
- Non-pharmacological treatment for comorbid substance use
- Clinical research
Related information
- Director of Research, Department of Psychiatry, Dalhousie University
- Nova Scotia Early Psychosis Program (NSHEPP); Early Psychosis Intervention Nova Scotia (EPINS)
- Dr. Tibbo is the Dr. Paul Janssen Chair in Psychotic Disorders (Dalhousie University) and Clinical Director of EPINS (Nova Scotia Health)
- Past-President, EPI Canada (www.epicanada.org)
Education
- B.Sc. Honours - Mount Allison University, NB
- B.Med.Sc. - Memorial University of Newfoundland
- MD - Memorial University of Newfoundland
- FRCPC - University of Alberta, Psychiatry
- AHFMR - Clinical Research Fellow, University of Alberta Psychiatry
Research interests
Dr. Tibbo investigates early phase psychosis/schizophrenia in the areas of service delivery, comorbid substance use, neuroimaging (MRS, DTI), and non-pharmacological treatment options for schizophrenia.
Selected publications
- Waldren I, Senger B, Cookey J, Crowne M, Tibbo P. (2022) Addressing Stigma and Promoting Help-Seeking Among African Nova Scotian Youth Experiencing Psychosis and Other Mental Health Problems. Canadian Journal of Psychiatry, 68(3), pp. 200-207.
- Senger B, Pencer A, Crocker CE, Simon P, Taylor B, Tibbo PG. (2024) The role of referral pathway to Early Intervention Services for psychosis on 2-year inpatient and emergency service use. Journal of Psychiatric Research. Volume 172, Pages 340-344.
- Snooks T, Tibbo, P.G., Romero-Sanchiz, P., DeGrace, S., Barrett, S., Bernusky, H., Stewart, S.H. (2024) The roles of cannabis potency and gender in cannabis dependence and anxiety in recent cannabis users with trauma exposure histories. Pharmacological Research, Volume 212, February 2025, Article 107586.
- Ahrens J, Ford SD, Schaefer B, Reese D, Khan AR, Tibbo P, Rabin R, Cassidy C, Palaniyappan L. (2025) Convergence of cannabis and psychosis on the dopamine system: A longitudinal neuromelanin-sensitive MRI study in cannabis use disorder and first episode schizophrenia. JAMA Psychiatry, Vol 82, No. 6.
- Nosko JAM., Crocker CE., Hambly Lapointe C, Tibbo, PG. (2025) Cannabis use in adolescence and young adulthood and its effects on brain structure and function: A scoping review. Frontiers in Psychiatry: Neuroimaging Volume 16 - 2025.
Selected awards and honors
- 2015 - Michael Smith Award, Schizophrenia Society of Canada, For research and leadership in schizophrenia
- 2017 - Champion of Mental Health Award (Researcher/Clinician category), awarded by the Canadian Alliance on Mental Illness and Mental Health
- 2018 - Prix d’excellence – Specialist of the Year (Region 5), Royal College of Physicians and Surgeons of Canada
- 2025 - Special Recognition Award, Department of Psychiatry, Dalhousie University, for unwavering reliability and leadership
Teaching
- Supervisor and co-supervisor of undergrad honours, MSc and PhD students
Service & Activity
- 2004 – 2010 Vice-Chair/Chair, Royal College of Physicians and Surgeons of Canada (RCPSC) Examination Committee and Board for Psychiatry
- 2012 – 2018 Chair, Schizophrenia Society of Canada Foundation
- 2016 – 2024 - President, Canadian Consortium for Early Intervention in Psychosis (CCEIP)
- 2017 – present - Scientific Advisor – “Cannabis and Psychosis” (cannabisandpsychosis.ca)
- 2021 – present - Chair, Board of Regents Student Affairs Committee - Mount Allison University